Loading clinical trials...
Loading clinical trials...
The Effects of Solriamfetol and CBT-I (Alone and in Combination) on Sleep Continuity, Sleepiness, Fatigue, and Performance in Patients With Insomnia Disorder
Conditions
Interventions
Solriamfetol 75 MG
Cognitive Behavioral Therapy for Insomnia (CBT-I)
+2 more
Locations
1
United States
University of Pennsylvania, Behavioral Sleep Medicine Program
Philadelphia, Pennsylvania, United States
Start Date
July 31, 2023
Primary Completion Date
January 31, 2026
Completion Date
April 30, 2026
Last Updated
May 21, 2025
NCT06032377
NCT06181643
NCT06807086
NCT07429578
NCT05780814
NCT06348082
Lead Sponsor
University of Pennsylvania
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions